Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
Ironwood Pharmaceuticals
IRWD
$712M
| $2.48M | ﹤0.01% |
560,464
-136,962
| -20% | -$556K |
|
5152
iShares US Industrials ETF
IYJ
$1.97B
| $2.48M | ﹤0.01% |
18,577
+12,187
| +191% | +$1.68M |
|
5153
PUT
Valvoline
VVV
$4.36B
| $2.48M | ﹤0.01% |
68,500
+37,600
| +122% | +$1.5M |
|
5154
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
| $2.48M | ﹤0.01% |
36,969
+4,982
| +16% | +$338K |
|
5155
CALL
Criteo S.A.
CRTO
$931M
| $2.48M | ﹤0.01% |
62,600
+31,700
| +103% | +$1.26M |
|
5156
PUT
Green Brick Partners
GRBK
$3.03B
| $2.47M | ﹤0.01% |
43,800
+17,300
| +65% | +$1.23M |
|
5157
PUT
Silicon Laboratories
SLAB
$7.29B
| $2.47M | ﹤0.01% |
19,900
-16,300
| -45% | -$1.87M |
|
5158
PUT
Equitable Holdings
EQH
$14.5B
| $2.47M | ﹤0.01% |
52,400
+28,500
| +119% | +$1.32M |
|
5159
BigBear.ai
BBAI
$1.57B
| $2.47M | ﹤0.01% |
+555,202
| New | +$1.26M |
|
5160
Main Street Capital
MAIN
$5.5B
| $2.47M | ﹤0.01% |
42,160
+41,610
| +7,565% | +$2.22M |
|
5161
CALL
ProShares Ultra Russell2000
UWM
$268M
| $2.47M | ﹤0.01% |
59,000
+38,200
| +184% | +$1.73M |
|
5162
CALL
Bausch + Lomb
BLCO
$6.09B
| $2.47M | ﹤0.01% |
136,700
+117,300
| +605% | +$2.29M |
|
5163
PUT
Champion Homes
SKY
$5.13B
| $2.47M | ﹤0.01% |
28,000
+2,000
| +8% | +$193K |
|
5164
Stantec
STN
$8.28B
| $2.46M | ﹤0.01% |
+31,414
| New | +$2.6M |
|
5165
First Trust RBA American Industrial Renaissance ETF
AIRR
$10.9B
| $2.46M | ﹤0.01% |
+31,980
| New | +$2.55M |
|
5166
VanEck Pharmaceutical ETF
PPH
$985M
| $2.46M | ﹤0.01% |
28,537
-35,813
| -56% | -$3.24M |
|
|
TPC
5167
PUT
Tutor Perini Cor
TPC
$5.09B
| $2.46M | ﹤0.01% |
101,700
+19,800
| +24% | +$538K |
|
5168
Gorman-Rupp
GRC
$2.13B
| $2.46M | ﹤0.01% |
64,887
-17,363
| -21% | -$694K |
|
5169
CALL
Direxion Daily MSFT Bull 2X ETF
MSFU
$696M
| $2.46M | ﹤0.01% |
62,300
+54,900
| +742% | +$2.32M |
|
5170
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$191M
| $2.46M | ﹤0.01% |
61,821
-27,615
| -31% | -$957K |
|
5171
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.3M
| $2.46M | ﹤0.01% |
47,397
+13,115
| +38% | +$693K |
|
|
AMWD
5172
DELISTED
American Woodmark
AMWD
| $2.45M | ﹤0.01% |
30,856
-14,532
| -32% | -$1.33M |
|
5173
PUT
Invesco Mortgage Capital
IVR
$805M
| $2.45M | ﹤0.01% |
304,700
+8,600
| +3% | +$72.2K |
|
5174
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
| $2.45M | ﹤0.01% |
643,221
-910,738
| -59% | -$4.91M |
|
5175
PUT
Brown-Forman Class B
BF.B
$13B
| $2.45M | ﹤0.01% |
64,500
+37,900
| +142% | +$1.67M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.